Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Nicholas Kennedy and Tariq Ahmad.
Nicholas Kennedy
Connection Strength
0.891
Tariq Ahmad
  1. Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11422 biologic-treated patients. J Crohns Colitis. 2021 Sep 02.
    View in: PubMed
    Score: 0.241
  2. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut. 2021 10; 70(10):1884-1893.
    View in: PubMed
    Score: 0.235
  3. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut. 2021 05; 70(5):865-875.
    View in: PubMed
    Score: 0.234
  4. Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for Therapeutic Drug Monitoring in patients with Inflammatory Bowel Disease. J Crohns Colitis. 2022 Feb 23; 16(2):190-198.
    View in: PubMed
    Score: 0.062
  5. SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply. Lancet Gastroenterol Hepatol. 2021 07; 6(7):523-524.
    View in: PubMed
    Score: 0.060
  6. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement. Lancet Gastroenterol Hepatol. 2021 03; 6(3):218-224.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.